Abstract

High-dose methotrexate is a crucial component of acute lymphoblastic leukaemia (ALL) treatment regimens. Adherence and tolerance to the treatment plan are critical factors to achieve the prognostic goals, therefore, any signs of toxicity should be taken into consideration.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call